Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance
- PMID: 19083400
- DOI: 10.1016/j.nutres.2008.01.008
Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance
Abstract
Oxidative stress is recognized widely as being associated with various disorders including diabetes, hypertension, and atherosclerosis. It is well established that hydrogen has a reducing action. We therefore investigated the effects of hydrogen-rich water intake on lipid and glucose metabolism in patients with either type 2 diabetes mellitus (T2DM) or impaired glucose tolerance (IGT). We performed a randomized, double-blind, placebo-controlled, crossover study in 30 patients with T2DM controlled by diet and exercise therapy and 6 patients with IGT. The patients consumed either 900 mL/d of hydrogen-rich pure water or 900 mL of placebo pure water for 8 weeks, with a 12-week washout period. Several biomarkers of oxidative stress, insulin resistance, and glucose metabolism, assessed by an oral glucose tolerance test, were evaluated at baseline and at 8 weeks. Intake of hydrogen-rich water was associated with significant decreases in the levels of modified low-density lipoprotein (LDL) cholesterol (ie, modifications that increase the net negative charge of LDL), small dense LDL, and urinary 8-isoprostanes by 15.5% (P < .01), 5.7% (P < .05), and 6.6% (P < .05), respectively. Hydrogen-rich water intake was also associated with a trend of decreased serum concentrations of oxidized LDL and free fatty acids, and increased plasma levels of adiponectin and extracellular-superoxide dismutase. In 4 of 6 patients with IGT, intake of hydrogen-rich water normalized the oral glucose tolerance test. In conclusion, these results suggest that supplementation with hydrogen-rich water may have a beneficial role in prevention of T2DM and insulin resistance.
Similar articles
-
Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.Clin Ther. 2005 Nov;27(11):1764-73. doi: 10.1016/j.clinthera.2005.11.006. Clin Ther. 2005. PMID: 16368447 Clinical Trial.
-
The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.Maturitas. 2006 Mar 20;53(4):430-8. doi: 10.1016/j.maturitas.2005.07.008. Epub 2005 Sep 27. Maturitas. 2006. PMID: 16198072 Clinical Trial.
-
Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.J Intern Med. 2006 Jun;259(6):553-60. doi: 10.1111/j.1365-2796.2006.01633.x. J Intern Med. 2006. PMID: 16704555 Clinical Trial.
-
[Proatherogenic lipid metabolism disturbances in impaired glucose tolerance].Pol Merkur Lekarski. 2005 Feb;18(104):219-22. Pol Merkur Lekarski. 2005. PMID: 17877135 Review. Polish.
-
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26. Acta Diabetol. 2009. PMID: 19322513 Review.
Cited by
-
Using oral molecular hydrogen supplements to combat microinflammation in humans: a pilot observational study.Int J Med Sci. 2024 Sep 9;21(12):2390-2401. doi: 10.7150/ijms.101114. eCollection 2024. Int J Med Sci. 2024. PMID: 39310256 Free PMC article. Clinical Trial.
-
Effects of hydrogen-rich water on blood uric acid in patients with hyperuricemia: A randomized placebo-controlled trial.Heliyon. 2024 Aug 15;10(16):e36401. doi: 10.1016/j.heliyon.2024.e36401. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39258191 Free PMC article.
-
The biological impact of deuterium and therapeutic potential of deuterium-depleted water.Front Pharmacol. 2024 Jul 22;15:1431204. doi: 10.3389/fphar.2024.1431204. eCollection 2024. Front Pharmacol. 2024. PMID: 39104389 Free PMC article. Review.
-
Effects of Molecular Hydrogen in the Pathophysiology and Management of Cardiovascular and Metabolic Diseases.Rev Cardiovasc Med. 2024 Jan 22;25(1):33. doi: 10.31083/j.rcm2501033. eCollection 2024 Jan. Rev Cardiovasc Med. 2024. PMID: 39077646 Free PMC article. Review.
-
Prospects of molecular hydrogen in cancer prevention and treatment.J Cancer Res Clin Oncol. 2024 Mar 31;150(4):170. doi: 10.1007/s00432-024-05685-7. J Cancer Res Clin Oncol. 2024. PMID: 38555538 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
